SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 307 filers reported holding SEATTLE GENETICS INC in Q4 2018. The put-call ratio across all filers is 1.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $6,053,000 | +22.1% | 31,045 | +6.4% | 0.01% | +11.1% |
| Q2 2020 | $4,958,000 | +72.9% | 29,185 | +17.4% | 0.01% | +28.6% |
| Q1 2020 | $2,868,000 | -22.1% | 24,855 | -23.4% | 0.01% | +16.7% |
| Q4 2019 | $3,681,000 | +80.8% | 32,444 | +36.0% | 0.01% | +50.0% |
| Q3 2019 | $2,036,000 | +741.3% | 23,850 | +582.2% | 0.00% | – |
| Q2 2019 | $242,000 | -24.8% | 3,496 | -16.2% | 0.00% | -100.0% |
| Q3 2018 | $322,000 | -48.8% | 4,171 | -64.5% | 0.00% | 0.0% |
| Q4 2017 | $629,000 | +8.8% | 11,751 | +10.7% | 0.00% | 0.0% |
| Q3 2017 | $578,000 | -9.8% | 10,614 | -14.2% | 0.00% | 0.0% |
| Q2 2017 | $641,000 | -60.9% | 12,374 | -52.0% | 0.00% | -66.7% |
| Q1 2017 | $1,641,000 | +179.1% | 25,799 | +131.5% | 0.00% | +200.0% |
| Q4 2016 | $588,000 | +55.1% | 11,144 | +42.1% | 0.00% | 0.0% |
| Q2 2015 | $379,000 | +37.3% | 7,842 | +0.3% | 0.00% | 0.0% |
| Q1 2015 | $276,000 | -0.4% | 7,822 | -9.4% | 0.00% | 0.0% |
| Q4 2014 | $277,000 | +21.0% | 8,629 | +44.3% | 0.00% | – |
| Q2 2014 | $229,000 | -30.8% | 5,980 | -17.9% | 0.00% | -100.0% |
| Q1 2014 | $331,000 | +33.5% | 7,281 | +17.5% | 0.00% | 0.0% |
| Q4 2013 | $248,000 | -6.1% | 6,194 | +2.9% | 0.00% | 0.0% |
| Q3 2013 | $264,000 | – | 6,017 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
| Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
| Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
| DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
| Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
| Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
| EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
| CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |